Changes in apomorphine pharmacodynamics following repeated treatment in 6-hydroxydopamine-lesioned rats

Brain Research

Volumn 729, Issue 2, 1996, Pages 190-196

  Gancher, Stephen ^a   Mayer, Andrea ^a   Youngman, Sara ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Apomorphine; Dose response relationship; Priming; Sensitization

Indexed keywords

APOMORPHINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; SENSITIZATION;

EID: 0030581281     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00421-0     Document Type: Article

References (41)

1. [1] Bevan, P., Repeated apomorphine treatment causes behavioral supersensitivity and dopamine D2 receptor hyposensitivity, Neurosci. Lett., 35 (1983) 185-189.
2. [2] Carey, R.I., Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra, Brain Res., 365 (1986) 379-382.
3. [3] Carey, R.J., Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model, Brain Res., 515 (1990) 292-298.
4. [4] Cash, R., Raisman, R., Ploaka, A. and Agid, Y., Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinsons disease, J. Neurochem., 49 (1987) 1075-1083.
5. [5] Castro, R., Abreu, P., Calzadilla, C.H. and Rodriquez, M., Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval, Psychopharmacology, 85 (1985) 333-339.
6. [6] Costall, B., Fortune, D.H., Naylor, R.J. and Nohria, V., A study of drug action on normal and denervated striatal mechanisms, Eur. J. Pharmacol., 56 (1979) 207-216.
7. [7] Crossman, A.R., Sambrook, M.A., Gergies, S.W. and Slater, P., The neurological basis of motor asymmetry following unilateral 6-hydroxydopamine brain lesions in the rat: the effect of motor decortication, J. Neurol. Sci., 34 (1977) 407-414.
8. [8] Deshaies, P., Bedard, P., Falardeau, P. and Di Paolo, T., Behavioral and biochemical evidence of apomorphine-induced supersensitivity of the striatal dopamine receptors, Neuropharmacology, 23 (1984) 1219-1222.
9. [9] Engber, T.M., Boldry, R.C., Kuo, S. and Chase, T.N., Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin, and enkephalin, Brain Res., 581 (1992) 261-268.
10. [10] Engber, T.M., Susel, Z., Kuo, S., Gerfen, C.R. and Chase, T.N., Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats, Brain Res., 552 (1991) 113-118.
11. [11] Fernandes, M., Kluwe, S. and Coper, H., Quantitative assessment of tolerance to and dependence on morphine in mice, Naunyn-Schmiedeberg's Arch. Pharmacol., 297 (1977) 53-60.
12. [12] Gancher, S.T., Nutt, J.G. and Woodward, W.R., Time course of tolerance to apomorphine in parkinsonism, Clin. Pharmacol. Ther., 52 (1992) 504-510.
13. [13] Herrera-Marschitz, M. and Ungerstedt, U., Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites, Eur. J. Pharmacol., 98 (1984) 165-176.
14. [14] Holford, N.H., MK Model: Users Manual, Elsevier, New York, NY, 1986.
15. [15] Holford, N.H.G. and Sheiner, L.B., Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models, Clin. Pharmacokin., 6 (1981) 429-453.
16. [16] Juncos, J.L., Engber, T.M., Raisman, R., et al., Continuous and intermittent levodopa differentially affect basal ganglia function, Ann. Neurol., 25 (1989) 473-478.
17. [17] Kalivas, P.W. and Stewart, J., Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity, Brain Res. Rev., 16 (1991) 223-244.
18. [18] Liebman, J.M., Gerber, R., Hall, N.R. and Altar, C.A., Heterogeneous rotational responsiveness in 6-hydroxydopamine-denervated rats: pharmacological and neurochemical characterization, Psychopharmacology, 96 (1988) 477-483.
19. [19] Mandel, R.J., Hartgraves, S.L., Severson, J.A., Woodward, J.J., Wilcox, R.E. and Randall, P.K., A quantitative estimate of the role of striatal D-2 receptor proliferation in dopaminergic behavioral supersensitivity: the contribution of mesolimbic dopamine to the magnitude of 6-OHDA lesion-induced agonist sensitivity in the rat, Behav. Brain Res., 59 (1993) 53-64.
20. [20] Mandel, R.J. and Randall, P.K., Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse, Brain Res., 330 (1985) 358-363.
21. [21] Mishra, R.K., Gardner, E.L., Katzman, R. and Makman, M.H., Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity, Proc. Natl. Acad. Sci. USA, 71 (1974) 3883-3887.
22. [22] Morelli, M., De Montis, G. and DiChiara, G., Changes in the D1 receptor-adenylate cyclase complex after priming, Eur. J. Pharmacol., 180 (1990) 365-367.
23. [23] Morelli, M., Fenu, S., Garau, L. and Di Chiara, G., Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity, Eur. J. Pharm., 162 (1989) 329-335.
24. [24] Morelli, M., Pontieri, F.E., Linfante, I., Orzi, F. and Di Chiara, G., Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist, Synapse, 13 (1993) 264-269.
25. [25] Neve, K.A., Kozlowski, M.R. and Marshall, J.F., Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity, Brain Res., 244 (1982) 33-44.
26. [26] Norman, A.B., Wyatt, L.M., Hildebrand, J.P., et al., Sensitization of rotation behavior in rats with unilateral 6-hydroxydopamine or kainic acid-induced striatal lesions, Pharmacol. Biochem. Behav., 37 (1990) 755-759.
27. [27] Oberlander, C., Dumont, C. and Boisser, J.R., Time course of apomorphine-induced circling behavior after striatal dopamine receptor denervation, Eur. J. Pharmacol., 62 (1980) 107-110.
28. [28] Olpe, H.R. and Koella, W.P., Rotatory behavior in rats by intranigral application of substance P and an eledoisin fragment, Brain Res., 126 (1977) 576-579.
29. [29] Rioux, L., Gagnon, C., Gaudin, D.P., Di Paolo, T. and Bedard, P.J., A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-DOPA in 6-OHDA rats. Correlation with D1 and D2 receptors, Neuroscience, 56 (1993) 45-51.
30. [30] Robertson, B.C., Hommer, D.W. and Skirboll, L.R., Electrophysiological evidence for a non-opioid interaction between dynorphin and GABA in the substantia nigra of the rat, Neuroscience, 23 (1987) 483-490.
31. [31] Robinson, T.E. and Becker, J.B., Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis, Brain Res. Rev., 11 (1986) 157-198.
32. [32] Rouillard, C., Bedard, P., Falardeau, P. and Di Paolo, T., Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion, Eur. J. Pharmacol., 157 (1988) 125-133.
33. [33] Rouillard, C., Bedard, P.J., Falardeau, P. and Dipaolo, T. Behavioral and biochemical evidence for a different effect of repeated administration of L-DOPA and bromocriptine on denervated versus non-denervated striatal dopamine receptors, Neuropharmacology, 26 (1987) 1601-1606.
34. [34] Schoenfeld, R. and Uretsky, N., Altered response to apomorphine in 6-hydroxydopamine-treated rats, Eur. J. Pharmacol., 19 (1972) 115-118.
35. [35] Schwarez, R., Fuxe, K., Agnati, L.F., Hokfelt, T. and Coyle, J.T., Rotational behavior in rats with unilateral striatal kainic acid lesions: a behavioral model for studies on intact dopamine receptors, Brain Res., 170 (1979) 485-495.
36. [36] Segal, D.S. and Kuczenski, R., Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates, J. Pharmacol. Exp. Ther., 242 (1987) 917-926.
37. [37] Setler, P.E., Malesky, M., McDevitt, J. and Turner, K., Rotation produced by administration of dopamine and related substances directly into the supersensitive caudate nucleus, Life Sci., 23 (1978) 1277-1284.
38. [38] Tonon, G., Saiani, L., Sopano, P.F. and Trabucchi, M., Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus, Brain Res., 160 (1979) 553-558.
39. [39] Ungerstedt, U., Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system, Acta Physiol. Scand. Suppl., 367 (1971) 69-93.
40. [40] Wilcox, R.E., Severson, J.A., Woodward, J.J., Randall, P.K., Vaughn, D.M. and Riffee, W.H., Behavioral sensitization following a single apomorphine pretreatment-selective effects on the dopamine release process, Brain Res., 528 (1990) 109-113.
41. [41] Winkler, J.D. and Weiss, B., Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice, J. Pharmacol. Exp. Ther., 249 (1989) 507-516.